Trials / Conditions / Wegener Granulomatosis

Wegener Granulomatosis

12 registered clinical trials studyying Wegener Granulomatosis.

Status	Trial	Sponsor	Phase
Unknown	Hydroxychloroquine in ANCA Vasculitis Evaluation NCT04316494	Guy's and St Thomas' NHS Foundation Trust	Phase 4
Active Not Recruiting	TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis NCT03919435	University of Pennsylvania	Phase 1 / Phase 2
Completed	Journey of Patients With Vasculitis From First Symptom to Diagnosis NCT03410290	University of Pennsylvania	—
Completed	Impact of Vasculitis on Employment and Income NCT02476292	University of South Florida	—
Unknown	Low-dose Glucocorticoid Vasculitis Induction Study NCT02198248	Chiba University	Phase 4
Completed	VCRC Patient Contact Registry Patient-Reported Data Validation Study NCT02190942	University of South Florida	—
Active Not Recruiting	The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach NCT01933724	University of South Florida	Phase 3
Completed	Rituximab Vasculitis Maintenance Study NCT01697267	Cambridge University Hospitals NHS Foundation Trust	Phase 3
Unknown	PRO Development for ANCA Associated Vasculitis NCT01729624	University of Oxford	—
Completed	Educational Needs of Patients With Systemic Vasculitis NCT02190929	University of South Florida	—
Completed	Vasculitis Illness Perception (VIP) Study NCT02190916	University of South Florida	—
Completed	Efficacy Study of Two Treatments in the Remission of Vasculitis NCT00748644	Assistance Publique - Hôpitaux de Paris	Phase 3